DE2745943C2 - - Google Patents

Info

Publication number
DE2745943C2
DE2745943C2 DE19772745943 DE2745943A DE2745943C2 DE 2745943 C2 DE2745943 C2 DE 2745943C2 DE 19772745943 DE19772745943 DE 19772745943 DE 2745943 A DE2745943 A DE 2745943A DE 2745943 C2 DE2745943 C2 DE 2745943C2
Authority
DE
Germany
Prior art keywords
sulfate
sodium
weight
glyceryl triacetate
blood
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE19772745943
Other languages
German (de)
English (en)
Other versions
DE2745943A1 (de
Inventor
Antonio Zannotti
Lidia Bologna It Bufalino
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ALFA FARMACEUTICI SpA BOLOGNA IT
Original Assignee
ALFA FARMACEUTICI SpA BOLOGNA IT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ALFA FARMACEUTICI SpA BOLOGNA IT filed Critical ALFA FARMACEUTICI SpA BOLOGNA IT
Publication of DE2745943A1 publication Critical patent/DE2745943A1/de
Application granted granted Critical
Publication of DE2745943C2 publication Critical patent/DE2745943C2/de
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
DE19772745943 1976-10-13 1977-10-12 Peroral verabreichbares arzneimittelpraeparat mit das blut normalisierender wirkung Granted DE2745943A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT356076A IT1069492B (it) 1976-10-13 1976-10-13 Composizione farmaceutica sommini stratrice per via orale contenente un fattore eparinoide sospeso in un veicolo oleoso costituito da triace tato di glicerina

Publications (2)

Publication Number Publication Date
DE2745943A1 DE2745943A1 (de) 1978-04-20
DE2745943C2 true DE2745943C2 (enrdf_load_stackoverflow) 1988-04-28

Family

ID=11109713

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19772745943 Granted DE2745943A1 (de) 1976-10-13 1977-10-12 Peroral verabreichbares arzneimittelpraeparat mit das blut normalisierender wirkung

Country Status (4)

Country Link
DE (1) DE2745943A1 (enrdf_load_stackoverflow)
GB (1) GB1563161A (enrdf_load_stackoverflow)
GR (1) GR71665B (enrdf_load_stackoverflow)
IT (1) IT1069492B (enrdf_load_stackoverflow)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3331009A1 (de) * 1983-08-27 1985-03-14 Basf Ag, 6700 Ludwigshafen Verfahren zur erhoehung der enteralen resorbierbarkeit von heparin bzw. heparinoiden sowie das so erhaeltliche heparin- bzw. heparinoidpraeparat
IT1245761B (it) * 1991-01-30 1994-10-14 Alfa Wassermann Spa Formulazioni farmaceutiche contenenti glicosaminoglicani assorbibili per via orale.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1062779B (it) * 1974-04-04 1985-01-14 Crinos Industria Farmaco Composizione farmaceutica contenente un fattore eparinoidico

Also Published As

Publication number Publication date
GB1563161A (en) 1980-03-19
DE2745943A1 (de) 1978-04-20
GR71665B (enrdf_load_stackoverflow) 1983-06-20
IT1069492B (it) 1985-03-25

Similar Documents

Publication Publication Date Title
DE69732049T2 (de) Pharmazeutische zubereitungen, enthaltend salze von hyaluronsäure und lokalanästhetika
EP1363618B1 (de) Pharmazeutische zusammensetzung zur behandlung von multiple sklerose
DE2905979C2 (de) Verwendung von acetylierten, destillierten Monoglyceriden zur Behandlung von Fettstoffwechselstörungen beim Menschen
DE2911670A1 (de) Arzneimittel zur therapeutischen behandlung von peripheren vaskularen erkrankungen
EP0712626A2 (de) Verwendung von R,S-(+/-)-alpha-Liponsäure, R-(+)-alpha-Liponsäure, S-(-)-alpha-Liponsäure in reduzierter oder oxidierter Form oder der Metabolite sowie deren Salze, Ester, Amide zur Herstellung von Rheologica
DE69400382T2 (de) Zusammensetzung zur Förderung des Lipidmetabolismus
DE69105767T2 (de) Bilobalid-Phospholipid-Komplexe, ihre Anwendung und Zusammensetzungen enthaltend diese.
DE3511609C2 (enrdf_load_stackoverflow)
DE3537656A1 (de) Verfahren zur herstellung von isosilybinfreiem silibinin und arzneimittel, enthaltend silibinin
DD144719A5 (de) Verfahren zur gewinnung einer natuerlichen polarfraktion mit antipsoriatischer wirksamkeit
DE69124609T2 (de) Verfahren zur Reinigung von komerziellen Karraghenanen
DE2514335C3 (de) Oral zu verabreichendes Arzneimittel mit Antiplasmin-Inhibitorwirkung
DE2611183A1 (de) Stabile dosierungsform von prostaglandinartigen verbindungen
DE69307895T2 (de) Therapeutische verwendung von phosphoryl-l-serin-n-acyl-sphingosin
DE2745943C2 (enrdf_load_stackoverflow)
DE2507635C2 (enrdf_load_stackoverflow)
DE3315482C2 (enrdf_load_stackoverflow)
EP0509042B1 (de) Intravenös applizierbare Pharmazeutische Zubereitung von 1-Octadecyl-2-methyl-glycero3-phosphocholin
DE2748291A1 (de) Triglyceride, verfahren zu ihrer herstellung und ihre verwendung zur behandlung von entzuendungen
DE3250048C2 (enrdf_load_stackoverflow)
DE2625053C3 (de) Arzneimittel zur Kontrolle von Leberkrankheiten
DE2736036A1 (de) Nicht-toxische polymere, verfahren zu deren herstellung und daraus hergestellte arzneimittel
DE2625220C3 (de) Arzneimittel zur Behandlung von Leberkrankheiten
DE2037942A1 (de) Arzneimittel zur Verhinderung der Atheroklerose und des Wiederauftretens kardiocaskulärer Anfälle bei atherosklerotischen Säugetieren
DE2038836C3 (de) Arzneimittel

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
8125 Change of the main classification

Ipc: A61K 31/725

D2 Grant after examination
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee